HLB Co., Ltd. Share Price

Equities

A028300

KR7028300002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
1,11,200 KRW +1.65% Intraday chart for HLB Co., Ltd. +4.61% +119.33%

Financials

Sales 2022 180B 132M 10.97B Sales 2023 42.9B 31.4M 2.62B Capitalization 6,542B 4.79B 399B
Net income 2022 -78.16B -57.21M -4.77B Net income 2023 -189B -138M -11.54B EV / Sales 2022 17.5 x
Net cash position 2022 168B 123M 10.23B Net cash position 2023 49.31B 36.09M 3.01B EV / Sales 2023 151 x
P/E ratio 2022
-40.6 x
P/E ratio 2023
-32.5 x
Employees 133
Yield 2022 *
-
Yield 2023
-
Free-Float 90.2%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.65%
1 week+4.61%
Current month+5.70%
1 month+5.70%
3 months+76.23%
6 months+280.17%
Current year+119.33%
More quotes
1 week
100 100.00
Extreme 100100
114 300.00
1 month
85 100.00
Extreme 85100
114 300.00
Current year
42 000.00
Extreme 42000
129 000.00
1 year
27 550.00
Extreme 27550
129 000.00
3 years
25 933.07
Extreme 25933.0726
129 000.00
5 years
9 048.35
Extreme 9048.3512
129 000.00
10 years
1 529.50
Extreme 1529.5034
129 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 -
Corporate Officer/Principal - -
Comptroller/Controller/Auditor 65 29/12/29
Members of the board TitleAgeSince
Director/Board Member 66 -
Chief Executive Officer 58 -
Director/Board Member 76 07/17/07
More insiders
Date Price Change Volume
02/24/02 1,06,500 -4.23% 1,376,513
30/24/30 1,11,200 +1.65% 2,081,958
29/24/29 1,09,400 -0.64% 1,177,733
26/24/26 1,10,100 +0.46% 2,387,462
25/24/25 1,09,600 +1.01% 1,700,986

End-of-day quote Korea S.E., April 30, 2024

More quotes
HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and pipes. The Company operates its business through two segments. The Composite Material segment is mainly engaged in the construction and repair of lifeboats, the manufacture and installation of pipes. The Biomedical Device Business segment is mainly engaged in the development of biopharmaceuticals, the manufacture and sale of medical devices.
More about the company
  1. Stock Market
  2. Equities
  3. A028300 Stock